Updated:
Mobia Medical
Duncan Stewart's Mobia Medical commercializes an FDA-cleared pressure-sensing overlay that prevents hospital bedsores, based in Toronto.
Mobia Medical
Mobia Medical was founded in Toronto in 2009 by Duncan Stewart. The firm traces its origins to a clinical need at a Canadian long-term care facility, where Stewart, then a respiratory therapist, built an early prototype to address pressure injuries in non-ambulatory patients. The company is not a family office or traditional fund — it functions as a private operating company that has raised capital to bring a regulated medical device to market. Mobia's strategy centers on a single core asset: the Mobia Smart Surface, a mattress overlay system that uses configurable air cells and embedded sensors to redistribute pressure continuously. The device holds FDA 510(k) clearance and Health Canada approval, positioning it for direct sales to hospitals, nursing homes, and home-care providers across North America. The firm participates in direct manufacturing contracts for the hardware and licenses its proprietary monitoring software to care networks. Known deployment has focused on the US rehabilitation hospital market and Canadian Veterans Affairs facilities. Co-investors or distribution partners are not publicly disclosed. The company maintains its headquarters and R&D operations in Toronto. Team size is not publicly filed. Stewart remains the public-facing executive, appearing in trade media and at wound-care conferences to present clinical trial data on the platform. No adjacent philanthropic structures or wealth-management vehicles are associated with the firm. Mobia's structural distinction lies in its regulated-device moat. Unlike software-only health startups, Mobia required multi-year FDA review to reach commercialization — a barrier that shapes its capital needs and extends its sales cycles, but also limits copycat risk in the pressure-injury prevention niche.
General information
Firm type
Asset Manager
Year founded
2009
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, ON, Canada
Principals
Duncan Stewart
CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Mobia Medical?
Mobia Medical operates as a private operating company under CEO Duncan Stewart, who founded the firm in 2009. Capital allocation decisions — including manufacturing scale-up, clinical trials, and sales-channel investments — are managed by Stewart and the management team, not a separate investment committee. The firm has not publicly disclosed outside investors or a board structure that governs deployment.
What regulatory approvals does the Mobia Smart Surface hold?
The device holds FDA 510(k) clearance in the United States and a medical device license from Health Canada. These approvals allow the system to be marketed as a Class II medical device for the prevention and treatment of pressure ulcers. The FDA clearance provides a competitive barrier that software-only health platforms cannot replicate in the wound-care market.
How does Mobia Medical source its sales pipeline?
The firm sells directly to institutional care providers — rehabilitation hospitals, long-term care facilities, and Veterans Affairs networks in North America. CEO Duncan Stewart has presented clinical outcomes at wound-care conferences, which serves as a primary sourcing channel for new pilot programs and purchase agreements. The firm has not disclosed relationships with group purchasing organizations or medical-device distributors.
Is Mobia Medical structured as a venture-backed startup or a family office?
Mobia Medical is a private operating company in the medical device space — not a venture firm, asset manager, or family office. It raises capital to fund its own operations and product commercialization. The firm has not publicly disclosed its cap table, and no institutional venture rounds have been widely reported.
What is the direct competitor set for Mobia's pressure-sensing overlay?
The market includes established low-air-loss mattress manufacturers like Hill-Rom (now Baxter) and Arjo, as well as sensor-enabled overlay startups. Mobia differentiates by offering continuous, automated pressure redistribution without nurse intervention — a feature set that positions it against both legacy static surfaces and newer smart-bed platforms from the major hospital-bed OEMs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: